These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
232 related articles for article (PubMed ID: 15540201)
1. Aberrant expression of serine/threonine kinase Pim-3 in hepatocellular carcinoma development and its role in the proliferation of human hepatoma cell lines. Fujii C; Nakamoto Y; Lu P; Tsuneyama K; Popivanova BK; Kaneko S; Mukaida N Int J Cancer; 2005 Mar; 114(2):209-18. PubMed ID: 15540201 [TBL] [Abstract][Full Text] [Related]
2. Accelerated hepatocellular carcinoma development in mice expressing the Pim-3 transgene selectively in the liver. Wu Y; Wang YY; Nakamoto Y; Li YY; Baba T; Kaneko S; Fujii C; Mukaida N Oncogene; 2010 Apr; 29(15):2228-37. PubMed ID: 20101231 [TBL] [Abstract][Full Text] [Related]
3. Serine/threonine kinase Pim-2 promotes liver tumorigenesis induction through mediating survival and preventing apoptosis of liver cell. Gong J; Wang J; Ren K; Liu C; Li B; Shi Y J Surg Res; 2009 May; 153(1):17-22. PubMed ID: 18675992 [TBL] [Abstract][Full Text] [Related]
4. Pim-3, a proto-oncogene with serine/threonine kinase activity, is aberrantly expressed in human pancreatic cancer and phosphorylates bad to block bad-mediated apoptosis in human pancreatic cancer cell lines. Li YY; Popivanova BK; Nagai Y; Ishikura H; Fujii C; Mukaida N Cancer Res; 2006 Jul; 66(13):6741-7. PubMed ID: 16818649 [TBL] [Abstract][Full Text] [Related]
5. Roles of Pim-3, a novel survival kinase, in tumorigenesis. Mukaida N; Wang YY; Li YY Cancer Sci; 2011 Aug; 102(8):1437-42. PubMed ID: 21518143 [TBL] [Abstract][Full Text] [Related]
6. Identification of stemonamide synthetic intermediates as a novel potent anticancer drug with an apoptosis-inducing ability. Li YY; Wang YY; Taniguchi T; Kawakami T; Baba T; Ishibashi H; Mukaida N Int J Cancer; 2010 Jul; 127(2):474-84. PubMed ID: 19921695 [TBL] [Abstract][Full Text] [Related]
7. A novel regulatory mechanism of Pim-3 kinase stability and its involvement in pancreatic cancer progression. Zhang F; Liu B; Wang Z; Yu XJ; Ni QX; Yang WT; Mukaida N; Li YY Mol Cancer Res; 2013 Dec; 11(12):1508-20. PubMed ID: 24165482 [TBL] [Abstract][Full Text] [Related]
8. Ubiquitous expression and cell cycle regulation of the protein kinase PIM-1. Liang H; Hittelman W; Nagarajan L Arch Biochem Biophys; 1996 Jun; 330(2):259-65. PubMed ID: 8660654 [TBL] [Abstract][Full Text] [Related]
9. Pim-3 promotes human pancreatic cancer growth by regulating tumor vasculogenesis. Liu B; Wang Z; Li HY; Zhang B; Ping B; Li YY Oncol Rep; 2014 Jun; 31(6):2625-34. PubMed ID: 24789328 [TBL] [Abstract][Full Text] [Related]
10. Expression of activation-induced cytidine deaminase in human hepatocytes during hepatocarcinogenesis. Kou T; Marusawa H; Kinoshita K; Endo Y; Okazaki IM; Ueda Y; Kodama Y; Haga H; Ikai I; Chiba T Int J Cancer; 2007 Feb; 120(3):469-76. PubMed ID: 17066440 [TBL] [Abstract][Full Text] [Related]
11. Loss of expression of Kruppel-like factor 6 in primary hepatocellular carcinoma and hepatoma cell lines. Wang SP; Zhou HJ; Chen XP; Ren GY; Ruan XX; Zhang Y; Zhang RL; Chen J J Exp Clin Cancer Res; 2007 Mar; 26(1):117-24. PubMed ID: 17550140 [TBL] [Abstract][Full Text] [Related]
12. Cloning and expression of CD24 gene in human hepatocellular carcinoma: a potential early tumor marker gene correlates with p53 mutation and tumor differentiation. Huang LR; Hsu HC Cancer Res; 1995 Oct; 55(20):4717-21. PubMed ID: 7553654 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-520e suppresses growth of hepatoma cells by targeting the NF-κB-inducing kinase (NIK). Zhang S; Shan C; Kong G; Du Y; Ye L; Zhang X Oncogene; 2012 Aug; 31(31):3607-20. PubMed ID: 22105365 [TBL] [Abstract][Full Text] [Related]
14. Pim-3 promotes the growth of human pancreatic cancer in the orthotopic nude mouse model through vascular endothelium growth factor. Wang C; Li HY; Liu B; Huang S; Wu L; Li YY J Surg Res; 2013 Dec; 185(2):595-604. PubMed ID: 23845873 [TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for hepatoma using a dual-function vector with both immunostimulatory and pim-3-silencing effects. Guo Q; Lan P; Yu X; Han Q; Zhang J; Tian Z; Zhang C Mol Cancer Ther; 2014 Jun; 13(6):1503-13. PubMed ID: 24723452 [TBL] [Abstract][Full Text] [Related]
16. A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma. de Thé H; Marchio A; Tiollais P; Dejean A Nature; 1987 Dec 17-23; 330(6149):667-70. PubMed ID: 2825037 [TBL] [Abstract][Full Text] [Related]
17. Essential contribution of Ets-1 to constitutive Pim-3 expression in human pancreatic cancer cells. Li YY; Wu Y; Tsuneyama K; Baba T; Mukaida N Cancer Sci; 2009 Mar; 100(3):396-404. PubMed ID: 19154409 [TBL] [Abstract][Full Text] [Related]
18. Differential expression of a cDNA clone in human liver versus hepatic cancer--highly homologous to aryl-dialkyl-phosphatase. Wang KK; Wan DF; Qiu XK; Lu PX; Gu JR Cell Res; 1997 Jun; 7(1):79-90. PubMed ID: 9261565 [TBL] [Abstract][Full Text] [Related]
19. Cloning, mapping, and characterization of the human sorbin and SH3 domain containing 1 (SORBS1) gene: a protein associated with c-Abl during insulin signaling in the hepatoma cell line Hep3B. Lin WH; Huang CJ; Liu MW; Chang HM; Chen YJ; Tai TY; Chuang LM Genomics; 2001 May; 74(1):12-20. PubMed ID: 11374898 [TBL] [Abstract][Full Text] [Related]
20. Biological function of a novel gene overexpressed in human hepatocellular carcinoma. Liu J; Zhou R; Zhang N; Rui J; Jin C Chin Med J (Engl); 2000 Oct; 113(10):881-5. PubMed ID: 11775832 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]